Enzo Biochem, Inc. operates as a vertically integrated bioscience company that focuses on delivering and applying advanced technology capabilities to produce products and services to allow its customers to meet their clinical needs. The company develops, manufactures, and sells its proprietary technology solutions and platforms to clinical laboratories, specialty clinics, and researchers and physicians worldwide. The company’s proprietary technology platforms reduce its customers’ need for multiple, specialized instruments, and offer various throughput capabilities together with a demonstrated high level of accuracy and reproducibility. Its genetic test panels are focused on markets primarily in the areas of personalized medicine, women’s health, infectious diseases and genetic disorders. The company’s AMPIPROBE technology platform could lead to the development of an entire line of nucleic acid clinical products that could allow laboratories to offer a menu of services at a cost that allows them to enjoy an acceptable margin. Its technology solutions provide tools to physicians, clinicians and other health care providers to improve detection, treatment and monitoring of a spectrum of diseases and conditions. Segments The company’s operates in three interconnected segments, which have evolved out of its core competencies involving the use of nucleic acids as informational molecules and the use of compounds for immune modulation and augmented by the previous acquisitions of various related companies. Enzo Clinical Labs: Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. Enzo Clinical Labs offers a menu of molecular and other clinical laboratory tests or procedures used in patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. The company operates a clinical laboratory in Farmingdale, New York, a network of approximately 30 patient service centers throughout New York and New Jersey, a free standing ‘STAT’ or rapid response laboratory in New York City and a phlebotomy, in-house logistics department, and information technology department. The company offers testing services to clinical laboratories and physicians in the majority of states nationwide. Enzo Life Sciences: Enzo Life Sciences manufactures, develops, and markets products and tools to clinical research, drug development and bioscience research customers worldwide. Enzo Life Sciences has developed proprietary products used in the identification of genomic information by laboratories worldwide. The company engages in the development, manufacturing validation and commercialization of various products serving the clinical research market and also life sciences researchers in the fields of cellular analysis and drug discovery, among others. Its operations are supported by global operations allowing for the marketing and delivery of its products worldwide. Enzo Therapeutics: Enzo Therapeutics is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. The company’s primary sources of revenue is from the clinical laboratory services provided to the healthcare community and product revenues and royalty and licensing of Life Sciences’ products utilized in life science research. Core Technologies The company has developed a portfolio of proprietary technologies with various research, diagnostic, and therapeutic applications. Gene analysis technology The company has developed AMPIPROBE a technology base for the labelling, detection, amplification, and formatting of nucleic acids for gene analysis, which is supported by its proprietary position in these fields. This and other proprietary technologies become the building blocks of the company’s Molecular Diagnostic platforms. Amplification The company has developed a proprietary amplification process for multicop
enzo biochem inc (EZB:Munich)
527 Madison Avenue
New York, NY 10022
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for EZB.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact ENZO BIOCHEM INC, please visit www.enzo.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.